A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxetecan in Patients with HRpositive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated with Endocrine Therapy (BEYOND)
2026-09-10
عنوان الدراسة
A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxetecan in Patients with HRpositive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated with Endocrine Therapy (BEYOND)
داعم الدراسة
AstraZeneca
دواء الدراسة
Trastuzumab
رقم بروتوكول الدراسة
D7814R0000
حالة الدراسة
Ongoing
موقع الدراسة
King Saud University Medical City (Riyadh)
مرحلة الدراسة
4
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.